Emergent BioSolutions Inc 2026年季度报告

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or Other Jurisdiction ofIncorporation or Organization) (240) 631-3200(Registrant's Telephone Number, Including Area Code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and(2) has been subject to such filing requirements for the past 90 days.☒Yes☐No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).☒Yes☐No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reportingcompany," and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filerNon-accelerated filer If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of July30, 2026, the registrant had 51,273,336 shares of common stock outstanding. Emergent BioSolutions Inc. and SubsidiariesForm 10-QTABLE OF CONTENTSPagePart I. Financial InformationItem 1.Financial Statements5Condensed Consolidated Balance Sheets—June 30, 2026 and December 31, 20255Condensed Consolidated Statements of Operations—Three and Six Months Ended June 30, 2026 and 20256Condensed Consolidated Statements of Comprehensive Income (loss) —Three and Six Months Ended June 30, 2026and 20257Condensed Consolidated Statements of Cash Flows—Six Months Ended June 30, 2026 and 20258Condensed Consolidated Statements of Changes in Stockholders' Equity—Three and Six Months Ended June 30, 2026and 20259Notes to Condensed Consolidated Financial Statements10Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations28Item 3.Quantitative and Qualitative Disclosures About Market Risk46Item 4.Controls and Procedures47Part II. Other InformationItem 1.Legal Proceedings48Item 1A.Risk Factors48Item 2.Unregistered Sales of Equity Securities and Use of Proceeds50Item 3.Defaults Upon Senior Securities50Item 4.Mine Safety Disclosures50Item 5.Other Information51Item 6.Exhibits51Signatures52 EMERGENT BIOSOLUTIONS INC. PART I. FINANCIAL INFORMATION CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q and the documents we incorporate by reference include forward-looking statements within themeaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, includingstatements regarding the future performance of Emergent BioSolutions Inc. or any of our businesses, our business strategy, futureoperations, future financial position, future revenues and earnings, our ability to achieve the objectives of our restructuring initiatives,acquisitions and divestitures, including our future results, projected costs, prospects, plans and objectives of management, are forward-looking statements. We generally identify forward-looking statements by using words like “anticipate,” “believe,” “continue,” “could,”“estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “may,” “plan,” “position,” “possible,” “potential,” “predict,” “project,”“should,” “target,” “will,” “would,” and similar expressions or variations thereof, or the negative thereof, but these terms are not theexclusive means of identifying such statements. These forward-looking statements are based on our current intentions, beliefs, assumptionsand expectations regarding future events based on information that is currently available. You should realize that if underlying assumptionsprove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. You are,therefore, cautioned not to place undue reliance on any forward-looking statement contained herein. Any such forward-looking statementspeaks only as of the date on which such statement is made and, except as required by law, we do not undertake any obligation to updateany forward-looking statement to reflect new informatio